-
A Look at 2021 Mergers and Acquisitions
SHEM OIRERE
December 17, 2021
The COVID-19 health crisis has introduced new dynamics in the global healthcare system while pushing leading pharmaceutical companies into investing more in research and development as others are enticed into mergers...
-
International trade officials to review impact of pharma mergers
europeanpharmaceuticalreview
March 19, 2021
The Federal Trade Commission will work with international regulators to review the effects of pharma mergers and update approaches to analysing them.
-
Federal Trade Commission forms multilateral working group on pharma mergers
pharmaceutical-technology
March 18, 2021
The US Federal Trade Commission (FTC) has launched a multilateral working group with domestic and international partners to reassess their approach to analysing the impacts of mergers and acquisitions (M&A) in the pharmaceutical industry.
-
Among recent megamergers, only AbbVie-Allergan looks like a winner
fiercepharma
July 28, 2019
When AbbVie announced its planned $63 billion takeout of Allergan last month, Wall Street blanched. Several analysts questioned whether the two companies were a good fit, blasting AbbVie for doing the deal solely to stave off the loss of revenues when its
-
Mergers Among Biotech Stocks Could Rise In 2019
firstwordpharma
December 25, 2018
According to analysts at RBC Capital Markets, Sarepta Therapeutics, Sage Therapeutics and Loxo Oncology are the most likely takeover targets among biotechnology firms in 2019, reported Investor's Business Daily. Sarepta is working on a gene therapy in a m
-
Trends in pharmaceutical mergers and acquisitions
biopharmadealmakers.nature
February 20, 2017
The number of mergers and acquisitions in the pharmaceutical industry has continued to rise, with oncology being a particularly active area and assets increasingly being acquired at earlier stages of their development.